ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
38 967,74
0,21%
DAX
18 498,38
0,32%
Brent Oil
83,46
0,72%
Bitcoin
62 178,10
-0,25%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) Actualités

TTNP

Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TTNP
DateHeureSourceTitreSymboleSociété
25/01/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
25/01/202422h29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
28/12/202322h15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
28/11/202322h47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
17/11/202322h03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
24/10/202323h26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
23/10/202321h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
16/10/202322h37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
04/10/202323h30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
19/09/202322h41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
18/09/202313h30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
14/08/202323h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
01/08/202301h45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
27/07/202313h30GlobeNewswire Inc.Titan Pharmaceuticals Announces Sale of Certain ProNeura AssetsNASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202322h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202322h06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202315h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202315h23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/05/202322h22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/04/202322h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
31/03/202322h36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/12/202213h00GlobeNewswire Inc.Titan Pharmaceuticals Provides Shareholder UpdateNASDAQ:TTNPTitan Pharmaceuticals Inc
12/12/202213h49GlobeNewswire Inc.UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.NASDAQ:TTNPTitan Pharmaceuticals Inc
30/08/202222h03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTNPTitan Pharmaceuticals Inc
16/08/202216h53PR Newswire (US)Titan Pharmaceuticals Announces Board Expansion and Management ChangesNASDAQ:TTNPTitan Pharmaceuticals Inc
25/07/202220h05Edgar (US Regulatory)Proxy Statement - Non-management (definitive) (defn14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
14/07/202218h48Edgar (US Regulatory)Proxy Statements Not Involving Contested Solicitations (preliminary) (pren14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202222h00Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202214h00GlobeNewswire Inc.Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of StockholdersNASDAQ:TTNPTitan Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TTNP

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
EU
CAP
Capgemini
EU
EN
Bouygues
NASDAQ
NVDA
NVIDIA
EU
AI
Air Liquide
EU
BNP
BNP Paribas
EU
GLE
Societe Generale
EU
VIV
Vivendi
NYSE
NKE
Nike
EU
HO
Thales
EU
DG
Vinci
EU
AF
Air FranceKLM
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés